ALGS股价触及52周低点6.71美元，面临市场挑战
Investing.com — Aligos Therapeutics Inc (ALGS)股价已触及52周低点，跌至6.71美元， InvestingPro ...
手机光明网 on MSN4 天
从进口药垄断中突围，国产长效干扰素助力乙肝“临床治愈”
近日，厦门特宝生物工程股份有限公司（简称“特宝生物”）发布了2024年年度报告，报告显示公司实现营收28.17亿元，同比增长34.13%；归属于上市公司股东的净利润达到8.28亿元，同比增长49%。
Aligos Therapeutics (NASDAQ:ALGS) Earns “Buy” Rating from HC Wainwright
Aligos Therapeutics (NASDAQ:ALGS – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently ...
Shore Capital Reiterates “House Stock” Rating for Inspired (LON:INSE)
Inspired (LON:INSE – Get Free Report)‘s stock had its “house stock” rating reiterated by stock analysts at Shore Capital in a research report issued on Monday, Marketbeat reports. Inspired Price ...
中国网财经中心6 天
从进口药垄断到国产破冰：特宝生物的“乙肝临床治愈”突围战
对于营收和净利双增长的原因，特宝生物表示，报告期内，公司主业稳健向好，尤其是随着乙肝临床治愈研究的不断深入，公司产品派格宾作为慢性乙肝抗病毒治疗的一线用药，进一步得到专家和患者的认可，产品持续放量，带动经营业绩实现较大增长。